Search Within

Nai-Kong Cheung

Formats
  1. Journal Article (411)
  2. Meeting Abstract (201)
  3. Conference Paper (14)
  4. Review (13)
  5. Book Section (11)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (652)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (652)
  3. GSK Faculty (652)
  4. Neuroblastoma Service (652)
  5. Pediatrics, Department of (652)
  6. Tow Center for Developmental Oncology (TCDO) (652)

More Groups

People
  1. Brian Kushner (227)
  2. Shakeel Modak (169)
  3. Kim Kramer (165)
  4. Steven Larson (108)
  5. Irene Cheung (92)
  6. Hong-Fen Guo (76)

More People

Years
  1. 2025 (9)
  2. 2024 (14)
  3. 2023 (21)
  4. 2022 (28)
  5. 2021 (20)
  6. 2020 (23)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Pediatric Blood and Cancer (67)
  3. Cancer Research (37)
  4. Journal of Nuclear Medicine (30)
  5. Clinical Cancer Research (24)
  6. Neuro-Oncology (22)

More Publications

Publishers
  1. American Association for Cancer Research (91)
  2. American Society of Clinical Oncology (72)
  3. Wiley Periodicals, Inc (70)
  4. Elsevier Inc. (37)
  5. Society of Nuclear Medicine (30)
  6. Oxford University Press (26)

More Publishers

Results (652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cells expressing cars directed against HLA-0201-Rmf WT-1 peptide complex can effectively eradicate WT1+A0201+ tumor cells in-vitro
    Meeting Abstract

    Kuo, T. Y.; Hasan, A. N.; Zhao, Q.; Selvakumar, A.; Tassev, D.; Cheung, N. K.; O'reilly, R.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
    Journal Article

    Kim, P. Y.; Tan, O.; Diakiw, S. M.; Carter, D.; Sekerye, E. O.; Wasinger, V. C.; Liu, T.; Kavallaris, M.; Norris, M. D.; Haber, M.; more...
    Journal of Proteomics (2014)

    Fulltext@MSK | Save
  • Intraperitoneal radioimmunotherapy (RIT) for desmoplastic small round cell tumor (DSRCT): Initial results from a phase I trial
    Meeting Abstract

    Modak, S.; La Quaglia, M. P.; Carrasquillo, J. A.; Zanzonico, P.; Enero, C.; Pandit-Taskar, N.; Kang, H. J.; Cheung, N. K. V.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Gene expression profiling of human neural crest stem cells and neuroblastomas identifies differential expression of embryologic and neural development genes
    Meeting Abstract

    Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2013)

    Fulltext@MSK | Save
  • Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma
    Journal Article

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases
    Journal Article

    Cobrinik, D.; Ostrovnaya, I.; Hassimi, M.; Tickoo, S. K.; Cheung, I. Y.; Cheung, N. K. V.
    Genes Chromosomes and Cancer (2013)

    Fulltext@MSK | Save
  • Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody
    Journal Article

    Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, N. K. V.
    Cancer (2013)

    Fulltext@MSK | Save
  • Hydrophilic F-18-labeled MIBG analogs for in vivo targeting of the norepinephrine transporter
    Meeting Abstract

    Zhang, H. W.; Huang, R. M.; Abou, D. S.; Cheung, N. K. V.; Thorek, D. L. J.; Zanzonico, P. B.; Blasberg, R. G.; Lewis, J. S.
    Journal of Labelled Compounds and Radiopharmaceuticals (2013)

    Fulltext@MSK | Save
  • Neuroblastoma: Developmental biology, cancer genomics and immunotherapy
    Journal Article

    Cheung, N. K. V.; Dyer, M. A.
    Nature Reviews Cancer (2013)

    Fulltext@MSK | Save
  • Early negative minimal residual disease in bone marrow after immunotherapy is less predictive of late or non-marrow relapse among patients with high-risk stage 4 neuroblastoma
    Journal Article

    Cheung, I. Y.; Feng, Y.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2013)

    Fulltext@MSK | Save